glp 1 agonists in development Glucagon-like peptide-1 receptor: mechanisms and advances therapy GLP-1 receptor agonists | How

Here's what researchers found.

In these cardiovascular safety trials, in secondary or exploratory analyses, GLP-1 receptor agonists were also shown to reduce macro-albuminuria, an accepted surrogate marker for diabetic kidney disease (DKD), a condition that still represents a major unmet medical need

Elon Musk wants to cut funding for scientific research, but the weight loss drugs he promoted also came from government funded basic science.

Patients who suffer from the adverse effects of the weight loss injections may file for compensation

Turn ordinary foods into functional superfoods with GLP-1 Daily Support, a 4-in-1 prebiotic blend that naturally aids appetite control, blood sugar balance, and metabolic health

Eli Lilly has just launched its newly approved GLP-1 product, Zepbound, in a direct-to-consumer approach